Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harrow Inc 1A Burton Hills Blvd. Suite 200 Nashville TN 37215 USA

www.harrow.com Employees: 315 P: 615-733-4730

Description:

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Key Statistics

Overview:

Market Capitalization, $K 1,249,196
Enterprise Value, $K 1,358,276
Shares Outstanding, K 35,615
Annual Sales, $ 130,190 K
Annual Net Income, $ -24,410 K
Last Quarter Sales, $ 49,260 K
Last Quarter Net Income, $ -4,220 K
EBIT, $ -8,580 K
EBITDA, $ 7,860 K
60-Month Beta 0.69
% of Insider Shareholders 13.67%
% of Institutional Shareholders 72.76%
Float, K 30,746
% Float 86.33%
Short Volume Ratio 0.54

Growth:

1-Year Return 244.94%
3-Year Return 270.43%
5-Year Return 332.49%
5-Year Revenue Growth 214.70%
5-Year Earnings Growth -208.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -0.80
EPS Growth vs. Prev Qtr 7.69%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/08/13

HROW Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -45.57%
Return-on-Assets % -8.87%
Profit Margin % -18.75%
Debt/Equity 3.23
Price/Sales 10.02
Price/Cash Flow N/A
Price/Book 22.56
Book Value/Share 1.62
Interest Coverage -0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar